Daniel K. Turner III

Daniel K. Turner III has been Board member and Chairman since October 2010. As managing director and a general partner at Montreux Equity Partners, a private investment company he founded in 1993. Also, currently serving as board directors of moksha8 Pharmaceuticals Inc and multiple companies, including Epirus Biopharmaceuticals, Inc., Glaukos Corporation, Orexigen Therapeutics, Inc., Renal CarePartners, Inc., Transcept Pharmaceuticals, Inc. and Tobira Therapeutics, Inc. Mr. Turner holds a bachelor’s degree from California State University, Sacramento.